8% SEries b CONVERTIBLE DEBENTURE DUE MARCH 31, 2017Catasys, Inc. • December 30th, 2016 • Services-misc health & allied services, nec • New York
THIS 8% SERIES B CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 8% Series B Convertible Debentures of CATASYS, INC., a Delaware corporation, (the “Company”), having its principal place of business at 11601 WILSHIRE BLVD, SUITE 1100, LOS ANGELES, CA 90025, designated as its 8% Series B Convertible Debenture due March 31, 2017 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
COMMON STOCK PURCHASE WARRANT CATASYS, INC.Catasys, Inc. • December 30th, 2016 • Services-misc health & allied services, nec • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, SHAMUS, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Catasys, Inc., a Delaware corporation (the “Company”), up to 264,706 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock 1/. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).
